These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29285848)

  • 1. Implementation of "clinical sequencing" in cancer genome medicine in Japan.
    Kohno T
    Cancer Sci; 2018 Mar; 109(3):507-512. PubMed ID: 29285848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study.
    Sunami K; Ichikawa H; Kubo T; Kato M; Fujiwara Y; Shimomura A; Koyama T; Kakishima H; Kitami M; Matsushita H; Furukawa E; Narushima D; Nagai M; Taniguchi H; Motoi N; Sekine S; Maeshima A; Mori T; Watanabe R; Yoshida M; Yoshida A; Yoshida H; Satomi K; Sukeda A; Hashimoto T; Shimizu T; Iwasa S; Yonemori K; Kato K; Morizane C; Ogawa C; Tanabe N; Sugano K; Hiraoka N; Tamura K; Yoshida T; Fujiwara Y; Ochiai A; Yamamoto N; Kohno T
    Cancer Sci; 2019 Apr; 110(4):1480-1490. PubMed ID: 30742731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients.
    Lee SH; Lee B; Shim JH; Lee KW; Yun JW; Kim SY; Kim TY; Kim YH; Ko YH; Chung HC; Yu CS; Lee J; Rha SY; Kim TW; Jung KH; Im SA; Moon HG; Cho S; Kang JH; Kim J; Kim SK; Ryu HS; Ha SY; Kim JI; Chung YJ; Kim C; Kim HL; Park WY; Noh DY; Park K
    Cancer Res Treat; 2019 Jan; 51(1):211-222. PubMed ID: 29690749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge base toward understanding actionable alterations and realizing precision oncology.
    Takeuchi S; Okuda S
    Int J Clin Oncol; 2019 Feb; 24(2):123-130. PubMed ID: 30542800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
    Oberg JA; Glade Bender JL; Sulis ML; Pendrick D; Sireci AN; Hsiao SJ; Turk AT; Dela Cruz FS; Hibshoosh H; Remotti H; Zylber RJ; Pang J; Diolaiti D; Koval C; Andrews SJ; Garvin JH; Yamashiro DJ; Chung WK; Emerson SG; Nagy PL; Mansukhani MM; Kung AL
    Genome Med; 2016 Dec; 8(1):133. PubMed ID: 28007021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Status and Impact of Clinical Tumor Genome Sequencing.
    Shaw KRM; Maitra A
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():413-432. PubMed ID: 30995147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor molecular profiling of NSCLC patients using next generation sequencing.
    Tsoulos N; Papadopoulou E; Metaxa-Mariatou V; Tsaousis G; Efstathiadou C; Tounta G; Scapeti A; Bourkoula E; Zarogoulidis P; Pentheroudakis G; Kakolyris S; Boukovinas I; Papakotoulas P; Athanasiadis E; Floros T; Koumarianou A; Barbounis V; Dinischiotu A; Nasioulas G
    Oncol Rep; 2017 Dec; 38(6):3419-3429. PubMed ID: 29130105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The possibility of clinical sequencing in the management of cancer.
    Kou T; Kanai M; Matsumoto S; Okuno Y; Muto M
    Jpn J Clin Oncol; 2016 May; 46(5):399-406. PubMed ID: 26917600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of amplicon-based next-generation sequencing in cancer.
    Chang F; Li MM
    Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
    Lim SM; Cho SH; Hwang IG; Choi JW; Chang H; Ahn MJ; Park KU; Kim JW; Ko YH; Ahn HK; Cho BC; Nam BH; Chun SH; Hong JH; Kwon JH; Choi JG; Kang EJ; Yun T; Lee KW; Kim JH; Kim JS; Lee HW; Kim MK; Jung D; Kim JE; Keam B; Yun HJ; Kim S; Kim HR
    Cancer Res Treat; 2019 Jan; 51(1):300-312. PubMed ID: 29747488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.
    Shimazawa R; Ikeda M
    Expert Rev Mol Diagn; 2020 Jun; 20(6):601-610. PubMed ID: 32064968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy according to next generation sequencing-based panel sequencing.
    Saito M; Momma T; Kono K
    Fukushima J Med Sci; 2018 Apr; 64(1):9-14. PubMed ID: 29628467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant classification in precision oncology.
    Leichsenring J; Horak P; Kreutzfeldt S; Heining C; Christopoulos P; Volckmar AL; Neumann O; Kirchner M; Ploeger C; Budczies J; Heilig CE; Hutter B; Fröhlich M; Uhrig S; Kazdal D; Allgäuer M; Harms A; Rempel E; Lehmann U; Thomas M; Pfarr N; Azoitei N; Bonzheim I; Marienfeld R; Möller P; Werner M; Fend F; Boerries M; von Bubnoff N; Lassmann S; Longerich T; Bitzer M; Seufferlein T; Malek N; Weichert W; Schirmacher P; Penzel R; Endris V; Brors B; Klauschen F; Glimm H; Fröhling S; Stenzinger A
    Int J Cancer; 2019 Dec; 145(11):2996-3010. PubMed ID: 31008532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution.
    Park HS; Lim SM; Kim S; Kim S; Kim HR; Kwack K; Lee MG; Kim JH; Moon YW
    PLoS One; 2016; 11(4):e0154133. PubMed ID: 27105424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors.
    Ananda G; Mockus S; Lundquist M; Spotlow V; Simons A; Mitchell T; Stafford G; Philip V; Stearns T; Srivastava A; Barter M; Rowe L; Malcolm J; Bult C; Karuturi RK; Rasmussen K; Hinerfeld D
    Exp Mol Pathol; 2015 Feb; 98(1):106-12. PubMed ID: 25562415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter experience with large panel next-generation sequencing in patients with advanced solid cancers in Japan.
    Kato S; Hayashi T; Suehara Y; Hamanoue H; Yamanaka S; Ichikawa Y; Higurashi T; Ohashi K; Yamaguchi S; Nozaki Y; Terao Y; Saito T
    Jpn J Clin Oncol; 2019 Feb; 49(2):174-182. PubMed ID: 30541038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next generation sequencing-based gene panel tests for the management of solid tumors.
    Nagahashi M; Shimada Y; Ichikawa H; Kameyama H; Takabe K; Okuda S; Wakai T
    Cancer Sci; 2019 Jan; 110(1):6-15. PubMed ID: 30338623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management.
    Hung SS; Meissner B; Chavez EA; Ben-Neriah S; Ennishi D; Jones MR; Shulha HP; Chan FC; Boyle M; Kridel R; Gascoyne RD; Mungall AJ; Marra MA; Scott DW; Connors JM; Steidl C
    J Mol Diagn; 2018 Mar; 20(2):203-214. PubMed ID: 29429887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.